Sugowell VG 1mg/500mg/0.2mg Tablet SR
Marketer
Meditouch Wellness
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sugowell VG 1mg/500mg/0.2mg Tablet SR
Diabetace Control 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Administer these tablets with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar. Discontinuing treatment without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, exercise, and weight management as advised by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular mealtimes and carry a fast-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability for pregnant or breastfeeding women requires medical consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Sugowell VG 1mg/500mg/0.2mg Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Sugowell VG 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugowell VG 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Sugowell VG 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
Common Side effects of Sugowell VG 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sugowell VG 1mg/500mg/0.2mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugowell VG 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet on an empty stomach.
How Sugowell VG 1mg/500mg/0.2mg Tablet SR works:
Tri-action antidiabetic tablet Sugowell VG (1mg/500mg/0.2mg sustained-release) combines three distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugowell VG 1mg/500mg/0.2mg Tablet SR with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Sugowell VG 1mg/500mg/0.2mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Consult your doctor for guidance.
Breast feedingCONSULT YOUR DOCTOR
The use of Sugowell VG 1mg/500mg/0.2mg SR tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Sugowell VG 1mg/500mg/0.2mg Tablet SR carries a high likelihood of risk for individuals with kidney impairment and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Sugowell VG 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiating treatment with a low dose of Sugowell VG 1mg/500mg/0.2mg Tablet SR is generally recommended; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Sugowell VG 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Sugowell VG 1mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Sugowell VG 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently